EGFR and non-small cell lung carcinoma: Another clue to support this notion is found in cases where erlotinib-resistant NSCLC cells have developed a mysterious HSP90-associated chaperone system to stabilize L858R/T790M-EGFR: it requires the help of cytosolic PKM255.